Category:Anti-SLAMF7 antibodies

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7), also commonly called CS1. Elotuzumab is the first FDA-approved medication in this category.

Pages in category "Anti-SLAMF7 antibodies"

This category contains only the following page.

E

Elotuzumab (Empliciti)

Retrieved from "https://hemonc.org/w/index.php?title=Category:Anti-SLAMF7_antibodies&oldid=43413"

Antineoplastic monoclonal antibodies